A Single Dose Study to Evaluate the Pharmacokinetics and Glucodynamics of insulin peglispro (LY2605541) in Healthy Male Japanese Subjects
Phase 1
- Conditions
- Healthy Volunteer
- Registration Number
- JPRN-jRCT2080222319
- Lead Sponsor
- Eli Lilly Japan K.K.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Sex
- Male
- Target Recruitment
- Not specified
Inclusion Criteria
Participants are overtly healthy male Japanese.
Participants have Body Mass Index (BMI) between 18.5 and 25.0 kilogram per square meter (kg/m^2), inclusive.
Exclusion Criteria
Participants have known allergies to insulin peglispro, related compounds.
Participants have a fasting venous blood glucose >108 milligram per deciliter (mg/dL) (>6 millimole per liter [mmol/L]).
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method